The objectives were to determine the body composition, and the effects of disease and corticosteroid therapy on body composition, in a population of female patients with systemic lupus erythematosus (SLE). All female SLE patients managed through a single centre were invited to participate in a cross-sectional study of body composition. Data were collected by standardized interview and examination, and review of medical records. Body composition was assessed by dual-energy X-ray absorptiometry (DXA). Eighty-two subjects were evaluated, 30 of whom were post-menopausal. Univariate linear regression analysis revealed a significant association of reduced fat-free mass with SLE severity [as measured by the Systemic Lupus International Collaborative Clinics (SLICC )] (P = 0.020), a history of corticosteroid exposure (P = 0.043) and age (P = 0.048). Reduced total body bone mineral density (BMD) was also significantly associated with SLICC (P < 0.001) and corticosteroid exposure (P = 0.017), and with age (P < 0.001), post-menopausal status (P = 0.003) and the duration of menopause (P < 0.001).
T study of body composition involves measurement DXA, considers the human body to consist of the sum of the individual components that constitute the human of the two principal components: fat mass and fat-free body. The components of the human body may be mass. The metabolic activity of the body occurs preclassified according to five levels of increasing complexdominantly in the fat-free mass and impaired immune ity, including atomic, molecular, cellular, tissue system competence has been reported in association with and whole body [1] . If all components at each level decreased fat-free mass [9, 10] . Furthermore, loss of are summed, the total is equivalent to body weight.
fat-free mass has been demonstrated to be a major Various methods are available for assessing body compredictor of survival for patients with acquired immune position at each level, including anthropometry, biodeficiency syndrome (AIDS) [11] , for acutely ill electrical impedance analysis, whole-body gamma patients in intensive care units [12] and for patients counting, in vivo neutron activation analysis, deuterwith cancer [13] . ium/tritium oxide dilution, and dual-energy X-ray
The body compositions of normal populations absorptiometry (DXA). Although further validation [14] [15] [16] and those with various life-threatening diseases studies are required [2, 3] , DXA has been demonstrated have been reported previously [11] [12] [13] . The interaction to be an accurate and precise method for assessing between body composition and chronic inflammatory body composition [4, 5] , and correlates highly with disease, however, is less well described. Reduced fatother methods such as underwater weighing [6 ] , deufree mass has been identified in patients with active terium oxide dilution [6 ] and total body potassium rheumatoid arthritis (RA), and increasing disability [7] . DXA directly measures the individual components has been reported in association with depletion of fatof body composition at the tissue-system level, and free mass even after adjusting for joint pain and disease includes quantification of fat mass ( FM ) and fat-free duration [17] . Systemic lupus erythematosus (SLE) is mass ( FFM ) which includes bone mineral content, a chronic systemic disease of unknown aetiology, which from which can be derived lumbar spine, femoral neck is characterized by immunologically mediated injury and total body bone mineral density (BMD).
in multiple body systems. Although several mechanSeveral models for body composition have been isms may contribute to alterations in body composition described according to the number of compartments in SLE, data on body composition changes in SLE are measured. These include two-compartment, threelimited [18] . Cytokines such as tumour necrosis factor compartment and four-compartment models [8] . The alpha ( TNF-a) are elevated in SLE [19] and these have two-compartment model, which may be assessed by been linked to loss of fat-free mass in other conditions [17, 20] . In addition, corticosteroids are a mainstay of therapy in SLE, and their effects on body composition composition, and the effects of disease and corticomass (g), soft-tissue mass (a measure of the combination of fat mass and fat-free mass) (g), bone mineral steroid therapy on body composition, in a female SLE population.
content (g), lumbar spine BMD (L2-4) (g/cm2), femoral neck BMD (g/cm2) and total body BMD (g/cm2) PATIENTS AND METHODS were measured. Results for fat-free mass were derived by subtracting fat mass from the soft-tissue mass and All SLE patients identified from the practices of rheumatologists affiliated to a single centre (Monash adding the bone mineral content. Fat mass and fatfree mass measurements were expressed in kilograms Medical Centre, Melbourne, Australia) were invited by mail to participate in a cross-sectional study of for univariate and stepwise multiple linear regression analyses. body composition. Non-respondents to the original letter were sent a reminder. Data were collected by a A simple linear regression was used to test the dependence of body composition (BMI, fat mass, fatstandardized interview, examination and review of medical records.
free mass and total body BMD) on the independent variables of age, menopausal status, duration of menoData recorded included date of birth, menopausal status (pre-or post-), age at menopause, duration of pause, duration of SLE, SLICC, corticosteroid ever and total corticosteroid dose. A simple linear regression menopause, dietary calcium intake (estimated from dietary questionnaire), estimated alcoholic intake (g) was also used to test the dependence of total body, lumbar spine and femoral neck BMD on the independconsumed daily, and number of packet-years of cigarettes smoked. women were excluded. Body height was measured to the nearest 0.5 cm in RESULTS subjects in the erect position without shoes, and body weight was measured to the nearest 100 g in subjects One hundred and twenty-two female SLE patients who fulfilled four or more classification criteria for wearing indoor clothes but no shoes. Body mass index (BMI ) was calculated as weight/height2 (kg/m2). SLE, as defined by the American College of Rheumatology revised criteria for SLE [23], were Body composition was measured by DXA using a Lunar DPX with Lunar software Version 3.6Y using identified, and 82 fulfilled inclusion criteria and consented to participate (response rate of 67%). Seven extended research analysis mode (Lunar Radiation Corp., Madison, WI, USA) as previously described [4, subjects were of South East Asian ethnic origin and the remainder were Caucasian. 5, 7, 25-27]. The underlying principle of DXA is based on the differential tissue attenuation of photons from
The median (range) age of participants was 41.0 (17.0-81.2) yr with a median (range) duration of SLE two energy levels from an X-ray source. DXA discriminates two substances in a given system and provides of 7.1 (0.1-41.8) yr. A large proportion of participants (61%) had a SLICC score of zero, consistent with low soft-tissue measurements from which per cent body fat and fat-free mass are computed, and estimates of total levels of disease-related accumulated organ damage. Fifty-seven subjects had been exposed to corticosterbody bone mineral content are obtained. The method of assessing body composition by using DXA relies oids at some stage in their disease, with a median (range) cumulative dose of 12.8 (0.5-85.4) g. Thirty almost totally on the manufacturer's equipment and the software for determining the compartments. The (37%) subjects were post-menopausal with a median (range) duration of menopause of 8.5 (1-38) yr. Of machine was calibrated daily using a quality assurance phantom and the interobserver coefficient of variation these, two were prematurely menopausal following cyclophosphamide therapy. No subjects were found to was 1% for body composition and 1% for BMD. Two operators were required for acquisition of the scans.
have disorders affecting body composition, including diseases of the thyroid or parathyroid. The entire body of each subject was scanned and fat tion measurements are useful in the assessment of endocrine, metabolic and nutritional disorders, and for Univariate linear regression analysis was performed to determine the relationships of clinical characteristics monitoring the effects of intervention programmes. Alterations in body composition, particularly depletion with body composition (Table I ) . Body composition variables studied included fat-free mass, fat mass, BMI, of fat-free mass, are known to occur in several disease states, including RA [17] . In RA, elevated cytokines total body BMD, and lumbar spine and femoral neck BMD. Fat-free mass was significantly negatively assoand corticosteroid therapy contribute to changes in body composition, and similar mechanisms may operciated with SLE disease severity (SLICC ), a history of corticosteroid exposure and age. An association of ate in SLE. We have recently reported, for example, the role of corticosteroid exposure in predicting lumbar reduced fat-free mass with total corticosteroid dose approached significance, but there was no association spine and femoral neck BMD in SLE [29] . The influence of SLE per se on body composition with the duration of SLE or with menopausal status. In contrast, fat mass was significantly associated with has not been studied previously. RA is known to have diverse deleterious effects on body composition, includmenopausal status and the association of fat mass with age approached significance. Fat mass was not signiing a decrease in fat-free mass and loss of bone mass [17, 21, 30, 31] . Indeed, the body composition changes ficantly associated with SLE-related variables or corticosteroid exposure. BMI was significantly associthat occur in RA parallel age-related changes; however, in RA, these occur independently of chronological age ated with menopausal status, but not with age, diseaserelated variables or corticosteroid therapy. Predictably, [32] . In a study of body composition in patients with RA, Roubenoff et al. [17] found that reduced fat-free BMI was significantly associated with both fat mass and fat-free mass.
mass, present in 67% of subjects, was significantly associated with disease activity, as assessed by the Univariate analysis of total body BMD revealed a significant negative association with SLE severity number of swollen joints, and with disability, even after adjusting for joint pain and disease duration. In (SLICC ), and a history of corticosteroid exposure, as well as with age, menopausal status and duration of addition, elevated levels of TNF-a were found in patients with active disease who were cachectic, but menopause. Total body BMD demonstrated a significant positive association with markers of body composinot in those with a normal fat-free mass. Similarly, in the present study, results of univariate analysis revealed tion, including BMI, fat mass and fat-free mass. Significant body composition associations of lumbar a significant association of SLE severity, measured using the SLICC tool, with reduced fat-free mass. Total corticosteroid dose, however, may have been a surrogate marker of disease severity. An important Stepwise multiple linear regression analysis was used to determine the relative contributions of clinical charadditional effect of SLE on body composition in the present study was the association of reduced total body acteristics, disease-related variables and corticosteroid therapy to body composition ( Table II ) . Fat-free mass BMD with disease severity. This finding has not been previously reported in SLE, but an association of was significantly negatively associated with age and total corticosteroid dose, but not with other diseasereduced lumbar spine and femoral neck BMD with disease activity has been reported in RA [30, 31] . related variables. Fat-free mass was also significantly associated with BMI, but not with menopausal status.
In addition to the effects of SLE on body composition, the influence of corticosteroids on body composiFat mass was significantly negatively associated with total corticosteroid dose, but not with other diseasetion was examined in the present study. Corticosteroids are a mainstay of therapy for SLE, and have multiple related variables. Fat mass was also significantly associated with BMI, but not with age or menopausal status.
effects on body composition [22] . They inhibit protein synthesis and stimulate protein degradation in skeletal Total body BMD was significantly negatively associated with SLE severity (SLICC ) and with menopausal muscle, resulting in net protein catabolism, decreased muscle mass, and hence reduced fat-free mass. In the duration, and positively associated with BMI and fatfree mass. Significant body composition associations present study, reduced fat-free mass was associated with both total cumulative corticosteroid dose and of lumbar spine BMD were fat-free mass (estimate [..], 0.009 [0.004], P = 0.025) and fat mass (estimate with corticosteroid ever. Similar results were reported by Houssiau et al. [18] , who found that corticosteroid [..], 0.013 [0.005], P = 0.008). Femoral neck BMD was also significantly associated with fat-free mass intake was negatively correlated with fat-free mass (as assessed by DXA) in 47 pre-menopausal SLE subjects, healthy elderly and contribute to age-related alterations in body composition [34] . During aging and the menoand by Roubenoff et al. [21] who demonstrated that high-dose corticosteroid therapy in RA causes nitrogen pause, several changes in body composition take place, including a decline in fat-free mass and total bone wasting (a measure of fat-free mass) despite an antiinflammatory and appetite-stimulatory effect.
mass, accompanied by an increase in fat mass [15, 34, 35] . In the present study, female SLE subjects demonAdditional reported effects of corticosteroids on body composition include a reduction in lumbar spine, strated similar changes, including an association of reduced fat-free mass and reduced total body BMD femoral neck and total body BMD, and a redistribution of fat without major changes in total fat mass [22] . In with advancing age. In addition, post-menopausal status and the duration of menopause were both the present study, reduced total BMD was found to be significantly associated with a history of corticoassociated with reduced total body BMD. Postmenopausal status was also associated with increased steroid exposure. Houssiau et al. [18] reported a similar effect of corticosteroids on total BMD in SLE. They fat mass.
In conclusion, this study demonstrates significant were, however, unable to demonstrate any association between corticosteroid exposure and fat mass. independent effects of both disease and corticosteroid therapy on body composition in SLE. Severe disease Paradoxically, in the present study, reduced fat mass was found to be significantly associated with total and corticosteroid exposure were found to be important independent predictors of both reduced total body corticosteroid dose. The effects of SLE per se on fat mass have not been previously reported, and it may BMD and reduced fat-free mass. This latter finding is of prognostic significance, given that reduced fat-free be that the association between higher corticosteroid doses and reduced fat mass is indeed a reflection of mass is associated with impaired immune competence, and has been shown to be a major predictor of survival more severe disease exerting a negative effect on fat mass.
in patients with AIDS, cancer and other lifethreatening illnesses. An additional finding in the curIn the current study, results of the multivariate analysis revealed a significant association of lumbar rent study was that fat-free mass appeared to be a more significant predictor of lumbar spine, femoral spine, femoral neck and total body BMD with fat-free mass, whereas only lumbar spine BMD was significneck and total body BMD than fat mass. The role of fat mass and fat-free mass in predicting lumbar spine, antly associated with fat mass. Previous data on the influence of fat mass and fat-free mass on bone density femoral neck and total body BMD in healthy pre-and post-menopausal women remains controversial, and in healthy pre-and post-menopausal women are conflicting. Earlier studies demonstrated a significant role has not been previously reported in SLE. There is a need for further studies to define more clearly the for fat mass in determining lumbar spine, femoral neck and total body BMD in post-menopausal women [32] .
impact of disease and corticosteroid therapy over time on body composition in SLE. Recently, in both pre-and post-menopausal non-obese women, fat-free mass has been reported to play a more A significant role than fat mass [33] , consistent with the findings of the present study. The lack of a control The authors acknowledge Drs Geoffrey Littlejohn, Marian Miller, Daniel Lewis, Timothy Woodruff, group in the present study, however, precluded comparison of BMD and body composition information Jennifer Harmer and Suzanne Piper for contributing patients to the study, and Dr Colin Rattray-Wood for of SLE patients with a control population.
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